← Back to Search

Patient Navigation for Gout (CARE-Gout Trial)

N/A
Recruiting
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
≥ 18 years old
Able to communicate and understand English or Spanish
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to improve the care for patients with gout, a painful joint condition that is becoming more common in the Southeastern U.S. The study also wants to increase the participation of minorities in

Who is the study for?
This trial is for individuals who have recently visited the emergency department (ED) for gout, a type of arthritis caused by excess uric acid. The study focuses on improving long-term care and acute treatment in the Southeastern U.S., with an emphasis on including African Americans.
What is being tested?
The intervention being tested is 'Patient Navigation,' which may involve personalized guidance and support to help patients manage their gout after an ED visit. The goal is to improve overall care and encourage minority participation in research.
What are the potential side effects?
Since this trial involves patient navigation rather than medication or medical procedures, there are no direct side effects associated with traditional clinical interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I can communicate and understand either English or Spanish.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Follow-Up Visit Addressing Gout within 3 Months

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Patient NavigationExperimental Treatment1 Intervention
A lay patient navigator will contact patients seen in the UAB ED via phone within \~72 hours following the ED visit. During this initial phone conversation, the navigators will: 1) conduct a baseline assessment to identify barriers to attending an outpatient visit for gout care and to adhering to gout treatment recommendations and 2) determine the level of support and assistance needed by the patient.
Group II: ControlActive Control1 Intervention
Usual Care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Patient Navigation
2017
Completed Phase 2
~38910

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,655 Previous Clinical Trials
2,443,958 Total Patients Enrolled
5 Trials studying Gout
41,807 Patients Enrolled for Gout
~133 spots leftby Jan 2026